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In Vivo Ablation of Surface Immunoglobulin
on Mature B Cells by Inducible Gene Targeting
Results in Rapid Cell Death
Kong-Peng Lam,* Ralf KuÈ hn, receptor cross-linking and transduced via signaling mo-
tifs in the cytoplasmic domains of the Iga/Igb hetero-and Klaus Rajewsky
Institute for Genetics dimer associated with both pBCR and BCR (Reth and
Wienands, 1997). While ablation of the cytoplasmic tailUniversity of Cologne
D-50931 Cologne of Iga indeed impedes B cell development (Torres et al.,
1996), the existence and nature of the ligands mediatingFederal Republic of Germany
receptor cross-linking at the developmental checkpoints
is still hypothetical. One speculation is that B cell devel-
opment, like that of T cells (Kisielow and von Boehmer,
Summary 1995), depends on low affinity interaction of the cells
with self-antigens in the local environment (Schwartz
Gene targeting experiments have demonstrated that and Stollar, 1994).
the expression of immunoglobulin heavy chain in the In this paper, we ask whether the dependence of
pre-B cell receptor (pBCR) and of heavy and light B-lineage cells on Ig expression early in development
chains in the B cell antigen receptor (BCR) marks continues into later maturation stages, as one might
checkpoints in early B cell development that the cells suspect given that Igexpression is the main raison d'etre
have to pass to survive. To investigate whether the for a mature B cell. We approach this question by gene
persistence of mature B cells in the peripheral immune targeting, which has already been instrumental in the
system also depends on BCR expression, we have identification of the early checkpoints in B cell develop-
generated a transgenic mouse in which the BCR can ment, marked by the expression of pBCR and BCR,
be inducibly ablated through V region gene deletion. respectively (Kitamura et al., 1991; Kitamura et al., 1992;
Ablation leads to rapid death of mature B lymphocytes, Torres et al., 1996). However, in its classical form, gene
which is preceded by down-regulation of MHC anti- targeting cannot be used for the analysis of the role of
gens and up-regulation of CD95 (Fas) and can be de- BCR on mature Bcells, since ablationof BCR expression
layed by constitutive bcl-2 expression. leads to a block of B cell generation altogether. We
overcome this problem (which is paradigmatic for the
analysis of any developmental process by gene tar-Introduction
geting) by using Cre-loxP-mediated inducible gene tar-
geting (KuÈ hn et al., 1995).Each B lymphocyte makes an antibody of a particular
antigen-binding specificity. This is achieved by somatic
recombination of gene segments encoding parts of the Results
antibody variable (V) region, called VH, DH, and JH for the
immunoglobulin (Ig) heavy (H) chain and VL and JL for Generation of Mice Allowing Inducible,
the Ig light (L) chain (Tonegawa, 1983). These gene re- Cre-Mediated Ablation
arrangements can either be in-frame or out-of-frame. of BCR Expression
Only cells with in-frame rearrangements of both the H For the generation of mice that allow inducible ablation
and L chains' V region gene segments and thus able of BCR expression, we modified an approach developed
to express an antibody survive the process of B cell previously, namely the positioning of an in-frame, re-
generation. arranged VHDHJH gene segment into its physiological
The control of cell survival by H and L chain expression location in the IgH locus by gene targeting (Taki et al.,
operates at specific checkpoints of control that cells 1993). The modification consisted of flanking the in-
have to pass during development. In man and mouse, serted V region gene and IgH intron enhancer (Em) by
most B cell progenitors first rearrange the V region gene loxP sites (ªfloxedº), thus making the targeted allele
segments of the H chain locus. If this results in an amenable to Cre recombinase±mediated deletion.
in-frame productive VHDHJH joint, the cells express a m The gene targeting strategy and characterization of
chain at the surface in the so-called pBCR complex. recombinant ES cells by Southern blotting and of the
This rescues the cell from apoptosis and signals it to corresponding Ig insertion mice by flow cytometry are
proceed to the next stage of development. Subsequent depicted in Figure 1. The inserted VHDHJH gene segment
in-frame rearrangement of VL and JL genes allows the was derived from the 4-hydroxy-3-nitrophenyl acetyl
cell to express surface Ig in the BCR complex, and only (NP)±binding antibody, B1-8 (Reth et al., 1978). Accord-
in doing so, the cell can make it into the peripheral ingly, we designate the mutant IgH allele B1-8f.
immune system and become a ªmatureº B cell (Rajew- As expected (Sonoda et al., 1997), B lymphopoiesis
sky, 1996). in the bone marrow of B1-8f/1 mice is normal, and the
The critical role of pBCR and BCR in B cell develop- size of the peripheral B cell pool in these mice is also
ment must involve signals transmitted to the cells via comparable to that of wild-type animals (data not
these receptors. These signals are likely generated by shown). Expression of the B1-8 H chain V region in
combination with l and most k L chains can be recog-
nized by the anti-idiotypic antibody, Ac146 (Reth et al.,
1979). Flow cytometric analysis of peripheral B cells in*To whom correspondence should be addressed.
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Figure 1. Generation of B1-8f/1 Ig Transgenic Mice
(A) Targeted insertion of the loxP-flanked B1-8 VDJ gene into the IgH locus. (1) Partial restriction endonuclease map of the wild-type IgH
locus. The closed circle represents the IgH intronic enhancer, and the closed boxes represent DQ52 and JH elements and Cm exons. Probes
used to verify the targeting events are indicated as (a), (b), and (c) together with the expected sizes of the restriction fragments. The restriction
sites are: (B), BamHI; (H), HindIII; and (P), PstI. Map is not drawn to scale. (2) Targeting vector used for the insertion of B1-8 VDJ. The DQ52
and JH elements of the IgH locus were replaced by the loxP-flanked neor gene and the B1-8 VDJ. A third loxP site was placed downstream
of the IgH Em enhancer. The closed triangles represent the loxP sites. Structure of the targeted IgH locus that has incorporated the third loxP
site (3), the locus after removal of the neor gene (4), and the locus upon full deletion of the targeted loxP-flanked B1-8 VDJ-Em fragment (5)
are shown. The sizes of the restriction fragments as revealed by the probes after homologous recombination and each subsequent deletional
event are indicated.
(B) Southern blot analyses of ES cell clones. Genomic DNA from parental E14 cells and clone 69 that gave germline transmission of the
modified IgH allele were digested with either BamHI, PstI, or HindIII and hybridized with probes (a), (b), and (c), respectively. Probe (a) was
used to verify the targeting event and subsequent deletion of the neor gene. Probe (b) was used to detect the cointegration of the third loxP
site. Finally, probe (c) distinguished subclones that had deleted only the neor gene or the neor gene and the entire loxP-flanked B1-8 VDJ-Em
fragment after transient transfection of homologous recombinants with a cre-expressing plasmid. Sizes of the wild-type and modified IgH
loci are shown.
(C) IgH allotype and idiotype expression on peripheral blood lymphocytes (PBL) from B1-8f/1 and control mice. PBLs of germline-transmitted
chinchilla offspring obtained from crosses of chimeric E14-CB20 males and CB20 females were analyzed by flow cytometry for (a) IgH allotype
and (b) B1-8 idiotype expression. E14- and CB20-derived B cells express ma and mb allotypes, respectively. PBLs were stained with FITC-anti-
mb and PE-anti-ma or FITC-anti-IgM and biotin-Ac146 (anti-B1-8) MAbs. The latter is revealed by streptavidin-PE. Numbers indicate percentages
of total lymphocytes.
B1-8f/1 mice indicates that the majority of the B cells and Em enhancer by two loxP sites has no deleterious
effect on the expression of the Ig transgene.(.70%) express the Ac146 idiotype (Figure 1C). In addi-
tion, heterozygous mice carrying the B1-8f allele of the
a allotype and a wild-type IgH allele of the b allotype
exhibit perfect allelic exclusion of the latter. In these Induced Deletion of the Antigen Receptor
on Mature B Cellsmice, more than 95% of the B cells express surface Ig
of the a allotype, in agreement with previous results To achieve induced deletion of the antigen receptor in
B cells, B1-8f/1 mice were crossed with Mx-cre mice(Sonoda et al., 1997). Together, these data indicate that
essentially all B cells in B1-8f heterozygous or homozy- that bear the Cre transgene under the control of type I
interferon (IFN)-inducible Mx promoter (KuÈ hn et al.,gous mice express the targeted Ig transgene. Further-
more, they show that the flanking of the V region gene 1995). In adult B1-8f/1, Mx-cre mice, BCR expression
Maintenance of Peripheral B Cells
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Figure 2. Induced Deletion of the Antigen Receptor
(A) Analysis of PBLs from IFN-induced B1-8f/1, Mx-cre mice before and 3 and 6 days after IFN injection. PBS-injected control B1-8f/1 and
B1-8f/1, Mx-cre mice gave results similar to those obtained in IFN-injected B1-8f/1 mice (data not shown).
(B) Analysis of B cells in various lymphoid organs of B1-8f/JHT, Mx-cre and control B1-8f/JHT mice 6 days after IFN treatment. Cells were
stained with PE-anti-B220 and FITC-anti-IgM MAbs. Numbers indicate percentages of total lymphocytes.
(C) Fraction of B cells present in the peripheral lymphoid organs of B1-8f/JHT, Mx-cre mice at various time points after IFN injection compared
to similarly treated B1-8f/JHT control. A group of 3±6 mice was analyzed for each time point. The number of B cells present in control B1-8f/
JHT mice are for Spl (3107): 5.6 6 0.6 (d0), 5.3 6 1.6 (d3), 4.9 6 1.7 (d6), 4.2 6 1.2 (d10), 6.1 6 0.7 (d20); for LN (3106): 2.1 6 0.2 (d0), 2.3 6
0.8 (d3), 2.2 6 0.3 (d6), 3.1 6 1.0 (d10), 2.6 6 0.8 (d20); for PerC (3105): 3.4 6 0.5 (d0), 5.0 6 2.6 (d3), 3.1 6 1.6 (d6), 5.9 6 2.6 (d10), 6.0 6
3.2 (d20). Abbreviations: (Spl), spleen; (BM), bone marrow; (PerC), peritoneal cavity; (LN), lymph nodes; and (d), day.
can be ablated by treatment of theanimals with recombi- B1-8f/1 and B1-8f/1, Mx-cre mice given phosphate-
buffered saline (PBS) (data not shown). The IgMlo popula-nant a/b IFN. Because B cells in heterozygous B1-8f
mice exhibit allelic exclusion and express only the tar- tion likely represents cells in which the B1-8f allele has
been deleted but which still retain some Ig on the cellgeted but not the wild-type IgH allele, the effect of the
induced deletion of the floxed B1-8 transgene can be surface due to protein turnover. In the blood, IgMlo cells
comprise approximately 15% of IgM1 cells 2 days afterdirectly assessed at the level of BCR expression in these
animals. IFN treatment of B1-8f, Mx-cre mice, and this increases
to 30% on day 6 before subsiding to background levelAs shown in Figure 2A, a population of B cells that
expresses low level of IgM (IgMlo) can be seen in the 2 weeks later (data not shown). Over time, as seen in
the analysis of peripheral blood lymphocytes (PBL) onperipheral blood of B1-8f/1, Mx-cre mice 2±3 days after
injection of IFN. This population is absent in B1-8f/1 day 6 (Figure 2A), there is a decrease in the proportion
of recirculating B cells in the blood of these animals.control mice injected with IFN (Figure 2A) as well as in
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IgMlo cells can also be detected at early time points in
the various lymphoid organs such as the spleen, bone
marrow and peritoneal cavity (Figure 2B), and lymph
nodes (data not shown, c.f. Figure 5A) of IFN-treated
B1-8f, Mx-cre mice.
B Cells without BCR Do Not Accumulate
in the Periphery
B1-8f/1, Mx-cre mice were further crossed with JHT/JHT
mice (in which both IgH alleles are inactivated [Gu et
al., 1993]) to derive B1-8f/JHT, Mx-cre offspring with one Figure 3. Deletion of the B1-8f Allele in Splenic Lymphocytes of B1-
IgH allele floxed and the other deleted. This allows easier 8f/JHT, Mx-cre Mice at Various Time Points after IFN Injection
quantitation of the B cells persisting in the periphery B and non-B cells (including T cells and macrophages) were isolated
from spleens of B1-8f/JHT, Mx-cre mice at various time points afterafter IFN injection as the influx of newly generated B
IFN injection and analyzed for the presence of the B1-8f allele bycells from the bone marrow that have deleted the B1-
Southern blotting. Genomic DNA was digested with HindIII and hy-8f allele and express H chain from the wild-type allele
bridized with probe (c) as shown in Figure 1. Bands corresponding
is prevented. In terms of B cell development and size to B1-8f and its deletion are indicated. The deleted B1-8f allele has
of the peripheral B cell pool, B1-8f/JHT mice are indistin- the same size as that of the JHT allele.
guishable from B1-8f/1 mice (data not shown).
IFN-induced deletion of the floxed IgH transgene in
of these cells to Cre expression and/or to the transientB1-8f/JHT, Mx-cre mice was rather efficient, as 6 days
introduction of DNA double-strand breaks in their ge-after induction, there were hardly any immature Ig1 B
nome by the Cre-mediated deletion process. However,cells left in the bone marrow (Figure 2B). Ten days after
the persistence of T cells with the deleted B1-8f alleleIFN injection, the B-lineage cells that were present in
(previous section) in IFN-treated B1-8f/JHT, Mx-cre micethe bone marrow consisted mainly of B2201 CD431
suggests, together with previous results (KuÈ hn et al.,pro-B and a few recirculating B cells (data not shown).
1995; Schwenk et al., 1995), that these events are notSimilarly, very few B cellswere present in the mesenteric
detrimental to mammalian cells in general and thus, areand inguinal lymph nodes 10 days after IFN injection,
unlikely to be the cause of the disappearance of B lym-and the number of splenic B cells was also substantially
phocytes that had deleted the B1-8f allele.reduced (Figure 2C). Quantification of Ig1 cells in IFN-
Another possibility for the disappearance of mutanttreated B1-8f/JHT, Mx-cre mice indicates that the loss
B cells could be due to the accumulation of aberrantof B cells was rapid in that the number of B lymphocytes
Cm protein from the deleted B1-8f allele, which couldwas significantly reduced (.60%) 10 days after IFN in-
be toxic to the cells. However, we consider this unlikely,jection. There were approximately 20% Ig1 B cells left
as deletion of the Em enhancer in vivo prevents Cm tran-in the spleen and between 5% and 15% B cells left in
scripts from being made (Gu et al., 1993).the lymph nodes (Figure 2C) 20 days after IFN treatment.
To show that the loss of peripheral B cells in IFN-The loss of B cells in the peritoneal cavity, however,
treated B1-8f/JHT, Mx-cre mice is indeed due to lack ofwas more gradual, perhaps reflecting a higher expres-
BCR expression, we generated mice that carry distinctsion level and/or a slower turnover of sIg on these cells.
VHDHJH insertions in their two IgH alleles, only one ofFlow cytometric analyses using two surface markers
which can be inducibly deleted. In such mice, most B(B220 and CD19) that are expressed on B-lineage cells
cells express H chains from both IgH alleles (Sonoda etrevealed that there was no accumulation of B2201 IgM2
al., 1997). Therefore, the loss of one IgH allele upon IFNor CD191 IgM2 cells in the peripheral blood or lymphoid
injection should still allow BCR expression and the cellsorgans of IFN-induced B1-8f/JHT, Mx-cre mice over time
should survive as ªsingle producers.º(Figures 2A and 2B), suggesting that such cells do not
B1-8f/1, Mx-cre mice were crossed with glD42i/1survive in vivo. This was confirmed by Southern blot
mice that carry a distinct functional ªknock-inº VHDHJHanalysis of purified splenic cells depleted of T cells and
segment to derive B1-8f/glD42i, Mx-cre offspring. Asmacrophages from B1-8f/JHT, Mx-cre mice at various
expected (Sonoda et al., 1997), most B cells in suchtimes after IFN injection. As seen in Figure 3, purified B
mice are allelically ªincludedº and express both heavycells obtained 2±5 days after IFN induction were en-
chain proteins on the cell surface, distinguishable fromriched for cells bearing the deleted Ig transgene. How-
each other by their constant region allotypes (B1-8f, a,ever, over time, these cells disappeared and were sub-
and glD42i, b).stituted by B cells in which the floxed Ig transgene had
B1-8f/glD42i, Mx-cre and B1-8f/glD42i control micenot been deleted by IFN treatment. In contrast, most T
were first given anti±interleukin 7 receptor antibodycells obtained from B1-8f/JHT, Mx-cre mice from day 6
(anti-IL7R MAb) to block B lymphopoiesis in the boneto day 20 after IFN injection harbored only the deleted
marrow (Sudo et al., 1993). This is tosimplify the analysisB1-8f allele. These cells persist because the BCR is not
of B cells in the periphery by preventing the generationexpressed in and not essential for T-lineage cells.
of new single IgH-expressing B cells in the bone marrow
after IFN-induced deletion of the B1-8f allele.Loss of Peripheral B Cells Is Due to Loss
Before induction of cre expression, the majority of theof BCR Expression
B cells in B1-8f/glD42i, Mx-cre mice coexpress both IgHThe disappearance of peripheral B cells in IFN-treated
B1-8/JHT, Mx-cre mice could be due to the sensitivity proteins, similar to control B1-8f/glD42i mice (depicted
Maintenance of Peripheral B Cells
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and B1-8/JHT control mice (data not shown). In contrast,
a large proportion (56%) of the IgMlo cells (fraction b) in
the mesenteric lymph node of B1-8f/JHT, Mx-cre mice
5 days after IFN treatment have decreased FSC, sug-
gesting that they are apoptotic cells. In addition, a new
population of cells (fraction c) is also detected in these
mice in which essentially all cells (87%) appear to be
apoptotic as indicated by their reduced size. This popu-
lation is not found in controlmice treatedwith IFN (Figure
5A) or PBS (data not shown).As a further internalcontrol,
most of the remaining IgMhi cells (fraction a) in the IFN-
treated B1-8f/JHT, Mx-cre mice have a normal FSC pro-
file similar to the viable lymphocytes in control mice.
Another characteristic of apoptotic cells is the loss of
cell membrane phospholipid asymmetry (Martin et al.,
1995). This can be detected by flow cytometry using
Annexin V (Koopman et al., 1994), which binds phospha-Figure 4. Deletion of the B1-8f Allele in IgH Double-Expressing B
tidylserine, a phospholipid that is confined to the innerCells
plasma membrane of viable cells but exposed on the(a) Flow-cytometric analysis of PBL from B1-8f/glD42i, Mx-cre and
outer plasma membrane of apoptotic and dead cells.B1-8f/glD42i control mice before IFN injection. Cells were stained
with FITC-anti-mb and PE-anti-ma MAbs. Apoptotic and dead cells can be further distinguished,
(b) Appearance of single IgH-expressing B cells in lymph node of as only the latter are stained by propidium iodide (PI).
B1-8f/glD42i, Mx-cre mice 9 days after IFN treatment (see text for Annexin V±positive cells are readily detected in the
details). Numbers indicate the fraction of cells expressed as percent-
spleens of IFN-injected B1-8f/JHT, Mx-cre mice. Twoage of total lymphocytes.
days after IFN injection, low levels of Annexin V±positive
cells (approximately 7% of total splenocytes)were found
for PBL in Figure 4). However, 9 days after IFN induction, in the spleen of B1-8f/JHT, Mx-cre mice (Figure 5B).
a population of IgHb ªonlyº B cells can be seen in lymph These cells, however, increase 2- to 3-fold in number
nodes (Figure 4), spleen, and peritoneal cavity of B1-8f/ (to approximately 20% of total splenocytes) 6 days after
glD42i, Mx-cre mice (data not shown). These are likely IFN treatment. In comparison, approximately 5% of the
peripheral B cells that have deleted the B1-8f allele but cells from control B1-8f/JHT mice 6 days after IFN injec-
remained viable as they possess a second BCR. They tion were Annexin V±positive. Further staining of these
are not newly generated single IgH-expressing B cells various samples revealed that only approximately 15%
that have emigrated from thebone marrow, as B lympho- of the Annexin V±positive cells were PI-positive, indicat-
poiesis in these mice had been blocked by prior treat- ing that most of these cells are indeed apoptotic cells
ment of anti-IL7R MAb. This was confirmed by flow (data not shown). Concomitant with the increase in
cytometric analysis of bone marrow cells from these Annexin V±positive cells, there was a decrease in the
mice that revealed the absence of a discrete population level of IgM1 cells in these IFN-treated B1-8f/JHT, Mx-cre
of immature B cells (data not shown). mice. Forty-five days after IFN injection in B1-8f/JHT,
Quantification of Ig1 B cells in the various lymphoid Mx-cre mice, at a time when B cells with deleted B1-8f
organs of IFN-treated B1-8f/glD42i, Mx-cre mice showed allele have disappeared (see Figure 3), the fraction of
that there was no reduction in the number of B cells Annexin V±positive cells is again at background level.
as compared to control B1-8f/glD42i mice that were Taken together, these data indicate that apoptotic
similarly treated (data not shown). Thus, double IgH- cells can be detected in situ in IFN-treated B1-8f/JHT,
expressing B cells that lose one BCR survive as single Mx-cre mice and suggest that mature B cells are likely
producers in the periphery. to undergo apoptosis upon loss of BCR expression.
Receptorless B Cells Likely Undergo
Apoptotic Cell Death Constitutive bcl-2 Expression Delays
the Death of Receptorless B CellsCells undergoing apoptosis are characterized by nuclear
chromatin condensation, size reduction, membrane bleb- Previous studies have shown that the protein encoded
by the mammalian proto-oncogene bcl-2 can preventbing, and finally, DNA degradation (Wyllie et al., 1980).
We used some of these parameters to examine B cells apoptotic cell death caused by a variety of stimuli and
enhance the survival of many cell types, including bothlosing BCR for signs of apoptosis.
Cell size is usually measured as forward scatter (FSC) immature and mature B lymphocytes, in vitro and in vivo
(Vaux et al., 1988; McDonnell et al., 1989; Strasser etin flow cytometry. Accordingly, apoptotic cells can be
detected as cells with reduced FSC compared to their al., 1991). Bcl-2 transgene expression has also been
shown to delay the elimination of autoreactive B cellsviable counterparts (Darzynkiewicz et al., 1991). As seen
in Figure 5A, cells that express a high level of surface (Hartley et al., 1993). This is of particular relevance to
the present study, as similar cellular mechanisms mayIgM (IgMhi, fraction a) in the mesenteric lymph node of
IFN-injected B1-8f/JHT control mice have a well-defined operate to eliminate autoreactive and nonfunctional B
cells. We therefore assessed whether constitutive bcl-2FSC profile, typical of viable lymphocytes. This is also
true for the IgMhi cells in PBS-injected B1-8/JHT, Mx-cre expression can rescue receptorless B cells from apo-
Cell
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Figure 5. Detection of Apoptotic Cells In Vivo
(A) Apoptotic cells, as revealed by size reduction (forward scatter measurement), are found in the mesenteric lymph node of B1-8f/JHT, Mx-
cre mice 6 days after IFN injection. Fraction (a) cells are the viable IgMhi cells. Fraction (b) (B2201 IgMlo) and (c) (B220intermediate) cells show
increased incidence of apoptosis and are not found in control B1-8f/JHT mice given IFN or B1-8f/JHT, Mx-cre and B1-8f/JHT mice given PBS
(not shown). Cells were stained with FITC-anti-IgM and PE-anti-B220 MAbs. Numbers indicate the percentage of cells undergoing apoptosis
within each fraction.
(B) Apoptotic cells revealed by Annexin V staining can be found in the spleens of IFN-injected B1-8f/JHT, Mx-cre mice. The fraction of Annexin
V±positive cells increases from day 2 to day 6 after IFN treatment in B1-8f/JHT, Mx-cre mice. For comparison, Annexin V staining of splenocytes
obtained from B1-8f/JHT control mice 6 days after IFN treatment is shown. Cells were stained with FITC-Annexin and PE-anti-IgM MAb.
Numbers indicate percentage of total cells analyzed.
ptotic cell death by introducing the Em-bcl-2-22 trans- in control B1-8f/1, bcl-2tg mice in the various lymphoid
organs examined except the peritoneal cavity. Together,gene (Strasser et al., 1991) into B1-8f/1, Mx-cre mice.
In the analyses presented in Figure 6 and Table 1, they represent only 50%±60% of the fraction of B-lin-
eage cells found in control animals. Thus, it appearsheterozygous mice (IgHB1-8f, a/1, b) were used. In these
B1-8f/1, Mx-cre and B1-8f/1, Mx-cre, bcl-2tg mice, that bcl-2 transgene expression delays but does not
prevent the disappearance of receptorless B cells. Thisbone marrow B cells could rearrange their wild-type
IgH allele upon IFN-induced deletion of the B1-8f allele. is evident in Figure 6, which shows the presence of a
distinct population of B2201 IgM2 cells in B1-8f/1, Mx-Thus, to get a more accurate representation of the effect
of bcl-2 transgene expression on cell survival, IgHb- cre, bcl-2tg mice 10 days after IFN injection (middle
panel) but no longer at a later time point (18 days, bottomexpressing B cells (i.e., cells that have rearranged the
wild-type allele) were excluded from the analysis. panel).
Ten days after IFN induction, a substantial fraction of
B2201 IgM2 cells is present in the spleen (Figure 6) as Loss of BCR Expression Results in Distinct
Phenotypic Changes on B Cellswell as in lymph nodes and peritoneal cavity (data not
shown) of B1-8f/1, Mx-cre, bcl-2tg mice. Sucha popula- To examine whether the loss of BCR expression could
affect the expression of other surface molecules, wetion is hardly detectable in similarly treated B1-8f/1,
Mx-cre and various other control mice (Figure 6 and compared IgMlo and IgMhi cells in IFN-treated B1-8f/
JHT, Mx-cre mice for the expression of various surfacedata not shown). This suggests that constitutive bcl-2
expression can rescue receptorless B cells from apo- markers.
As expected, the IgMlo cells have lower surface ex-ptosis. However, comparison of the number of Ig2 and
IgHa1 B cells in IFN-treated B1-8f/1, Mx-cre, bcl-2tg pression of IgD and k or l L chains compared to B cells
in control mice, consistent with the notion that the floxedmice to the number of B cells found in similarly treated
B1-8f/1, bcl-2tg control mice indicates that this rescue IgH locus is deleted (data not shown). Intracellular stain-
ing of IgMlo cells also indicates that there was no accu-is only partial. As shown in Table 1, the sum of B2201
Ig2 and B2201 IgMa1 cells in B1-8f/1, Mx-cre, bcl-2tg mulation of L chains in the cytoplasm of these cells (data
not shown), in agreement with reports stating that Ldoes not equal the number of B2201 IgMa1 cells found
Maintenance of Peripheral B Cells
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Table 1. Number of Ig1 and Ig2 B Cells in IFN-Treated B1-8f/1, bcl-2tg, Mx-cre Mice
B1-8f/1, bcl-2tg B1-8f/1, bcl-2tg, Mx-cre
B2201 IgMa1 B2201 Ig2 B2201 IgMa1 B2201 Ig2
Sp1 (3 106) 84.7 6 8.1 5.5 6 1.3 16.1 6 5.1 (19%) 30.8 6 7.1 (36%)
LN (3 105) 60.4 6 14.2 2.1 6 1.0 13.1 6 4.2 (21%) 28.6 6 9.0 (47%)
PerC (3 104) 58.7 6 15.8 2.7 6 1.4 31.1 6 16.6 (52%) 26.5 6 18.4 (45%)
Mice were given IFN intravenously every 3 days and analyzed on day 10 after the initiation of treatment. Newly formed B cells of mb allotype
were excluded from the analyses (see text for details). Numbers in parentheses indicate cells in B1-8f/1, bcl-2tg, Mx-cre mice expressed as
percentages of the B2201 IgMa1 cells in control mice. Groups of 3±5 mice were analyzed. Abbreviations: Spl, spleen; LN, lymph nodes; PerC,
peritoneal cavity.
chains are secreted or degraded in the absence of IgH and CD40, which are molecules involved in the activa-
chains (Dul et al., 1996). This argues against the possibil- tion of B cells, were also expressed at equivalent levels
ity that the disappearance of B cells that have deleted between IgMlo and IgMhi cells in these mice, as were the
the B1-8f allele is due to the accumulation of uncom- adhesion molecules CD49d (alpha 4 integrin), CD62L
plexed L chains in the cytoplasm that could be toxic to (L-Selectin), and integrin b7 chain (data not shown).
the cells. Interestingly, major histocompatibility complex (MHC)
Several cell surface molecules have been implicated Class I and Class II antigens, molecules involved in the
in the modulation of BCR signaling. Of these, CD19, presentation of peptides toT cells, weredown-regulated
CD38, and CD45 (B220) were found to be expressed at on IgMlo cells in IFN-treated B1-8f/JHT, Mx-cre mice (Fig-
similar levels on IgMhi and IgMlo cells in IFN-treated B1- ure 7). This down-regulation of MHC Class I and II was
8f/JHT, Mx-cre mice and on B cells in IFN and PBS- not due to IFN as the IgMhi cells in the same IFN-treated
injected control mice (data not shown). Similarly, CD23 mice expressed these MHC antigens at levels compara-
ble to those in PBS-injected controls. Thus, the down-
regulation of MHC Class I and II antigens is a result of
the reduced level of BCR expression on B cells that
have deleted the B1-8f allele.
In contrast to the decreased expression of MHC mole-
cules, the expression of Fas (CD95)Ða cell surface mol-
ecule involved in programmed cell death (Nagata and
Golstein, 1995)Ðis up-regulated on IgMlo cells in IFN-
injected B1-8f/JHT, Mx-cre mice (Figure 7). This up-regu-
lation of Fas is again not due to IFN since IgMhi cells in
the same IFN-treated mice as well as in the various
Figure 6. Effect of Constitutive bcl-2 Transgene Expression on the
Survival of Receptorless B Cells
Figure 7. Phenotypic Changes of B Cells Losing BCR ExpressionConstitutive bcl-2 transgene expression delays but does not prevent
the elimination of receptorless B cells. Analysis of splenic lympho- MHC Class I and II and Fas expression on IgMlo (unshaded histo-
gram) and IgMhi cells (shaded histograms) from IFN-injected B1-8f/cytes showing the presence at day 10 (middle left panel) and ab-
sence at day 18 (bottom left panel) of a disinct population of B2201 JHT, Mx-cre mice (upper panel) or IgMhi cells from B1-8f/JHT control
mice injected with either IFN or PBS (middle and lower panels). SeeIgM2 cells after IFN treatment in B1-8f/1, Mx-cre, bcl-2tg mice (see
text for details). Spleen cells obtained from B1-8f/1, bcl-2tg; B1- Figure 2 for definition of IgMlo and IgMhi cells. Cells were stained
with FITC-anti-IgM, PE-anti-B220, and biotin-anti-MHC class I, bio-8f/1, Mx-cre; and B1-8f/1 mice 10 days after being given IFN are
shown for comparison. Numbers indicate percentage of total lym- tin-anti-MHC class II, or biotin-anti-Fas MAbs, revealed with Strep-
tavidin-Cychrome.phocytes.
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control mice did not have increased level of Fas expres- (Strasser et al., 1994) showing that constitutive bcl-2
expression leads to the accumulation of sIgM2 B cellssion. Thus, the loss of BCR expression on mature B
cells leads to an increased level of Fas expression. with mature phenotype in severecombined immunodefi-
ciency (scid) mice in which the assembly of V regionTaken together, the results suggest that the loss of
BCR expression on mature B lymphocytes induces the genes is genetically impaired. However, the scid pheno-
type is ªleakyº (Bosma and Carroll, 1991) in that V regioncells to selectively modulate the expression of certain
cell surface molecules. These specific changes could gene rearrangements occasionally occur in the progeni-
tor population. Thus, the sIgM2 B cells observed byin turn influence the fate of these cells.
Strasser et al. (1994) may represent the progeny of rare
progenitors that have acquired in-frame V region geneDiscussion
rearrangements, migrated to the periphery, undergone
isotype switching, and accumulated due to excessiveEssential Role of the BCR in Developing
antigenic stimulation. Indeed, this seems likely as con-and Mature B Cells
stitutive bcl-2 expression did not lead to an accumula-The expression of a functional pBCR and, later, BCR is
tion of sIgM2 B cells with mature phenotype in recombi-central for early B cell development (Rajewsky, 1996).
nation-deficient (Rag22/2) mice (Young et al., 1997).Thus, in mouse mutants unable to express a pBCR, B
Thus, even if survival signals through the BCR result incell development is blocked at the pro-B cell stage of
bcl-2 up-regulation, the latter alone is not sufficient fordifferentiation (Kitamura et al., 1991, 1992; Mombaerts
the persistence of mature B cells.et al., 1992; Shinkai et al., 1992) but can be rescued by
The distinct changes of cell surface phenotype ob-the introduction of functional immunoglobulin L and/or
served in B cells that lose BCR expression suggest thatH chain transgenes (Spanopoulou et al., 1994; Young
the immune system may have evolved strategies in addi-et al., 1994; Pelanda et al., 1996). Similarly, when the
tion to cell-autonomous apoptosis, to ensure the elimi-expression or signaling competence of a pBCR and/or
nation of nonfunctional B lymphocytes. Thus, the up-BCR is compromised, cells are eliminated at the pre-B
regulation of Fas expression on receptorless B cellscell stage of development or are prevented from seeding
could render these cells susceptible to T cell±mediatedthe peripheral immune system (Gong and Nussenzweig
killing, in analogy to the putative elimination of autoreac-1996; Torres et al., 1996). We now show that mature B
tive B cells through a Fas±Fas ligand (FasL)±mediatedcells, having passed through these early checkpoints in
mechanism (Rathmell et al., 1995). In this process, Tdevelopment and selected into the long-lived peripheral
cell±derived signals, initiated by CD40±CD40 ligandpool, still depend on the expression of BCR for their
(CD40L) interaction, finally result in Fas-mediated B cellpersistence. Ablation of BCR leads to death of mature
death, unless the cells are rescued by coactivationB cells. Thus, the data presented in this paper build
through the T cell antigen receptor, a reaction that de-upon the basic principle of B cell development, namely,
pends on antigen processing via the BCR (Rathmell etthat B lymphocytes are continuously being selected for
al., 1996). Thus, it is possible that BCR ablation deprivestheir ability to express a functional antibody and that
B cells of a signal to suppress Fas up-regulation causednonfunctional B cells and their progenitors are rapidly
by CD40±CD40L interaction, thereby making them tar-removed from the immune system.
gets of cytotoxic T cells (Rothstein et al., 1995; Lagresle
et al., 1996). Experiments are now underway to test this
Elimination of Receptorless B Cells possibility by crossing B1-8f/1, Mx-cre with T cell±
Why are mature B cells devoid of BCR not maintained deficient (Mombaerts et al., 1991), Fas-deficient, and
in the peripheral immune system? The most straightfor- CD40L-deficient (Xu et al., 1994) mice.
ward interpretation of this phenomenon is that the BCR Similarly, the down-regulation of MHC class I antigens
provides a survival signal to these cells. Such a signal on receptorless B cells could make them targets for
could be B cell±autonomous and depend upon the as- natural killer (NK) cells. Murine MHC class I molecules
sembly of the BCR complex as such (Reth and Wie- have been shown to interact with the Ly-49 receptors
nands, 1997) or its interaction with other molecules on expressed on subsets of NK cells and inactivate NK
the B cell surface. Alternatively, B cell survival could be cell±mediated cytotoxiciy (Karlhofer et al., 1992). NK
mediated by low levelsignals generated by (low affinity?) cell±mediated elimination of cells lacking MHC class I
interaction of the BCR with self or environmental anti- molecules has been demonstrated for certain tumor
gens. This relates to the old and still unresolved problem cells (KaÈ rre et al., 1986) and normal lymphoblasts from
of whether B cells, in analogy to T cells (Kisielow and b2-microglobulin-deficient mice (Liao et al., 1991).
von Boehmer, 1995; Takeda et al., 1996), require ligand- Whether NK cells indeed contribute to the elimination
mediated positive selection for their entry and persis- of nonfunctional B lymphocytes awaits future experi-
tence in the peripheral immune system (Gu et al., 1991; ments in which one would deplete NK cells in vivo.
Schwartz and Stollar, 1994). Further insights into these
matters could come from analyses of the downstream
components of the signaling chain leading to B cell A Common Mechanism for the Elimination
of Useless and Potentiallyelimination as described here, again using inducible
gene targeting. Harmful B Cells?
While the present system of induced BCR ablation isIt is interesting to note that constitutive bcl-2 expres-
sion was unable to fully rescue receptorless B cells from artificial, B cells losing BCR expression must naturally
arise through spontaneous somatic mutation, and atapoptosis. This seems to contradict a previous report
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the targeted and wild-type IgH alleles were 2.7 and 3.6 kb, respec-high rate, through somatic hypermutation in the germi-
tively. Of 100 double drug-resistant ES cell clones,12 were identifiednal center reaction that is the basis of the generation
as homologous recombinants and confirmed by Southern blottingof high affinity B cell memory (Rajewsky, 1996). The
as shown in Figure 1. BamHI-digested genomic DNA from PCR-
mechanisms by which such cells are eliminated may positive clones were hybridized with external probe a to yield bands
well resemble those involved in theelimination of autore- of 9 and 15 kb for wild-type and targeted loci, respectively. To
screen for clones that have cointegrated the third loxP site, PstI-active cells generated in the bone marrow or later, in
digested genomic DNA from homologous recombinants were hy-germinal centers. In accord with this notion, the cell
bridized with internal probe b. The presence of a new 1.4 kb bandsurface phenotype of B cells that lose BCR expression
indicates the cointegration event. The frequency of cointegration ofresembles that of ªtransitionalº B cells that have yet to
the third loxP site was about 40%.
be selected into the long-lived peripheral pool (Carsetti To delete the neor gene in vitro, targeted ES cell clones were
et al., 1995) and of ªanergicº B cells that have down- transiently transfected with a cre-encoding plasmid, pIC-Cre (30
mg/107 cells). DNA from neo-sensitive clones were digested withregulated BCR expression due to chronic exposure to
HindIII and hybridized with probe c. Bands of 3.3 and 1.8 kb indicatea self-antigen (Hartley et al., 1993). As in the case of
targeted loci with neor or total deletion, respectively. Approximatelytransitional and anergic B cells, B cells that lose BCR
48% of the neo-sensitive clones had only deleted the neor gene.expression up-regulate Fas. In addition, transitional and
Two ES cell clones bearing the rearranged VHB1-8 and without
receptorless B cells have low levels of MHC class II the neor gene were injected into blastocysts of CB.20 mice and
expression (Carsetti et al., 1995). Finally, similar to what transplanted into the uteri of F1 (BALB/c 3 C57BL/6) fosters. Chime-
ric mice were mated with CB.20 mice for germline transmissionwe see in receptorless B cells, constitutive bcl-2 expres-
of the targeted IgH allele. Tail DNA from chinchilla offspring weresion delays but does not rescue anergic B cells from
analyzed by PCR and Southern blotting as described above.elimination when they compete with wild-type cells (Hart-
ley et al., 1993; Cyster et al., 1994). Useless and poten-
Mouse Strains
tially harmful B cells may thus be eliminated by a similar The Mx-cre (KuÈhn et al., 1995), JHT (Gu et al., 1993) and glD42i
mechanism. This raises the interesting possibility that (Sonoda et al., 1997) mice used in this study were bred and main-
also a mechanism of cellular rescue, namely the genera- tained in our animal facilities. The Em-bcl-2-22 (Strasser et al., 1991)
transgenic mouse strain was obtained from The Jackson Laboratorytion of a novel BCR through secondary V region gene
(Bar Harbor, Maine, USA). The bcl-2 transgene was identified byrearrangements (ªreceptor editingº), identified in cells
intracellular stainings of PBLs with MAb 2/100 (Alexis) for the humanescaping autoreactivity (Gay et al., 1993; Tiegs et al.,
bcl-2 protein. Mice used in the experiments were .6 weeks old.
1993), may operate in both situations. While there is
indirect evidence for receptor editing in germinal center Induced Deletion of the BCR
B cells (Han et al. 1996; Hikida et al., 1996), its possible B1-8f/1 mice were crossed with Mx-cre (KuÈ hn et al., 1995) mice or
sequentially with JHT/JHT (Gu et al., 1993) and Mx-cre mice to gener-initiation upon BCR ablation in the present system re-
ate B1-8f/1, Mx-cre or B1-8f/JHT, Mx-cre mice. These transgenicmains to be investigated.
mice were genetically a mixture of strains 129, CB20, and C57BL/6.
For the induction of Cre expression and subsequent deletion of
BCR, mice were given three doses of recombinant a/b IFN (2 3 106Experimental Procedures
U/dose) intravenously on days 0, 3, and 6 and analyzed at various
time points thereafter. Control mice were given PBS. For the analysisConstruction of the B1-8VDJEmf Targeting Vector
of double IgH-expressing B cells, B1-8f/glD42, Mx-cre and B1-8f/The construction of the targeting vector consisted of a modification
glD42 control mice were first given two doses of 1 mg of anti-IL7Rof the short arm of homology of the vector pIVhL2neor (Sonoda et
MAb (A7R34) intravenously to inhibit B lymphopoiesis in the boneal., 1997). A 1.1 kb fragment containing the Em enhancer was ampli-
marrow (Sudo et al., 1993). One week later, the mice were treatedfied by polymerase chain reaction (PCR) from genomic DNA of 129/
with IFN as above for the induction of B1-8f allele deletion andOla-derived E14.1 ES cell line using primers 59-TGTCTATCGATCTC
analyzed 9 days later.AGAGGC-39 and 59-CGGGAAGCTTGAACTACTCAA-39. This fragment
To assess the degree of B1-8f gene deletion, cells were isolatedwas cloned into plasmid pKL-1 that contains a single loxP site to
from different organs of B1-8f/JHT, Mx-cre mice at various timederive plasmid pKL-2. A second 1.1 kb intronic fragment down-
points after IFN injection for Southern blot analysis. Splenic lympho-stream of the Em enhancer and including the 39 Matrix Attachment
cytes were further separated into B and non-B cells by MACS (Mil-Region was amplified using primers 59-CTTGAATTCGGACTTTAGT
tenyi) using anti-CD43 MAb±coupled magnetic beads. The purity ofCTCTTTAATT-39 and 59-ACATCTAGAGAGTTGTAGATCAAGAATG-39
B cells obtained by this procedure is usually .90%.and cloned into pBluescript to obtain pKL-3. Subsequently, a 2
kb SalI±HindIII fragment containing the B1-8VDJ and the 1.2 kb
Flow CytometryHindIII±EcoRI fragment containing the Em enhancer and a single
Cells obtained from the various lymphoid organs of mice wereloxP site was cloned into EcoRI±SalI-digested pKL-3 in a three-
stained with fluorochrome (fluorescein isothiocyanate, FITC; phy-way ligation to obtain pKL-4. Finally, the loxP-flanked B1-8VDJEm
coerythrin, PE) or biotin-conjugated monoclonal antibodies for flowfragment was excised as a XhoI±NotI fragment and cloned into
cytometric analyses on a FACScan (Becton Dickinson). Biotin-con-pIVhL2neor to generate the B1-8VDJEmf targeting vector.
jugated MAbs were revealed with streptavidin-Cychrome or PE. The
following MAbs were prepared in our laboratory: R33-24-12 (anti-
IgM), 1.3-5 (anti-IgD), R33-18-10, and LS136 (anti-k and -l L chains),Transfection of ES Cells and Generation of B1-8f Mice
RS3.1 (anti-ma), MB86 (anti-mb), RA3±6B2 (anti-B220), M5-114 (anti-The procedures used for the culture and transfection of embryonic
MHC Class II), H141-29 (anti-MHC Class I), and Ac146 (anti-B1-8).stem (ES) cells and subsequent generation of mutant mice follow
MAbs to the following cell surface antigens were purchased fromthat of published protocols (Torres and KuÈhn, 1997). E14.1 ES cells
Pharmingen: CD3, CD19, CD24, CD38, CD40, CD62L, CD69, and(1 3 107) were transfected with NotI-linearized targeting vector (30
CD95 (Fas).mg) by electroporation and selected with G418 (350 mg/ml) and
Gancyclovir (2 mM). Double resistant colonies were identified by
PCR using a 59 primer (59-CAAGGCACCACTCTCACAGTCT-39) that Apoptotic Cell Assays
Apoptotic B cells were identified ex vivo by Annexin V (Boehringeranneals to the JH2 element in the B1-8VDJ and a 39 primer that is
located external to the targeting construct (59-TGTGGATCCAGACT Mannheim) staining in flow cytometric analyses. Cells were stained
according to the manufacturer's instructions.TAGTCCAGCCG-39). The expected sizes of the PCR fragments from
Cell
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